Joseph S. Shan
Overview
Joseph S. Shan received an average of $569K in total compensation, including $271K in salary, at Peregrine Pharmaceuticals from 2012 to 2018.
2018Peregrine PharmaceuticalsFormer Vice President, Clinical & Regulatory Affairs
2017Peregrine PharmaceuticalsFormer Vice President, Clinical & Regulatory Affairs
2016Peregrine PharmaceuticalsFormer Vice President, Clinical & Regulatory Affairs
2014Peregrine PharmaceuticalsVice President, Clinical & Regulatory Affairs
2013Peregrine PharmaceuticalsVice President, Clinical & Regulatory Affairs
2012Peregrine PharmaceuticalsVice President, Clinical & Regulatory Affairs
Source: SEC filings on August 17, 2018 and August 28, 2014.
Related executives
We found 13 more executives who work or worked at Peregrine Pharmaceuticals.
Nicholas Green
Peregrine Pharmaceuticals
Chief Executive Officer
Daniel Hart
Peregrine Pharmaceuticals
Chief Financial Officer
Mark Ziebell
Peregrine Pharmaceuticals
General Counsel
Matthew Kwietniak
Peregrine Pharmaceuticals
Chief Commercial Officer
Richard Richieri
Peregrine Pharmaceuticals
Chief Operations Officer
Richard Hancock
Peregrine Pharmaceuticals
Chief Executive Officer
Roger Lias
Peregrine Pharmaceuticals
Chief Executive Officer
Stephen Hedberg
Peregrine Pharmaceuticals